All AstraZeneca articles – Page 3
-
Business
Teva wins generic esomeprazole race
US approval of heartburn drug after Ranbaxy version was withdrawn by regulators
-
-
Business
Big pharma opens up abandoned drugs
Seven firms will make 68 stalled compounds available for academic research
-
Business
Ranbaxy sues over withdrawn US approvals
Company says decision is ‘unconstitutional’ and deprives it of hundreds of millions of dollars in revenue
-
Business
Piramal exits drug discovery in India
Company will concentrate on generic medicines and clinical and contract research.
-
Business
Clinical collaborations drive cancer immunotherapy
Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
-
Business
Illumina targets cancer diagnostics
Sequencing will improve tests and speed up clinical trials processes for big pharma partners
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
-
BusinessPharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
OpinionMessy megamergers
Big company buyouts are more about immediate gains and rarely consider the impact on research, says Derek Lowe
-
Business
Time called on Pfizer–AstraZeneca deal
Pfizer could make a fresh approach after six months under City takeover rules
-
Business
AstraZeneca refuses Pfizer’s ‘final’ offer
Pfizer pledges not to make hostile bid direct to shareholders
-
BusinessPfizer presses hard for AstraZeneca deal
Executives face down international controversy over tax schemes and previous post-merger record
-
Business
Pharma giants plan new public–private collaborations
AstraZeneca and GSK will partner with UK academics to work on early drug discovery
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier
-
Business
AstraZeneca ends R&D in India
Bangalore site will close with loss of 168 jobs. Some projects will transfer to UK
-
CareersGeneration next
AstraZeneca is investing in the future of drug discovery with its new graduate training scheme in pharma. Manisha Lalloo finds out more
-
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page